BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6969768)

  • 1. Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.
    Cohen I; Potter EV; Glaser T; Entwistle R; Davis L; Chediak J; Anderson B
    J Lab Clin Med; 1981 Jan; 97(1):134-40. PubMed ID: 6969768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on aggregation of platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Tatewaki W; Hanano M; Nagayama R; Shibata A
    Thromb Haemost; 1986 Jun; 55(3):338-41. PubMed ID: 3018956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
    Clemetson KJ; Clemetson JM
    Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.
    Turitto VT; Weiss HJ; Baumgartner HR
    J Lab Clin Med; 1983 Oct; 102(4):551-64. PubMed ID: 6413629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing susceptibilities of platelets from normal individuals and patients with von Willebrand's disease to attack by quinine- and quinidine-dependent antiplatelet antibodies.
    Pfueller SL; Bilston RA; Logan D; David R; Sloan IG; Firkin BG
    Thromb Haemost; 1989 Feb; 61(1):111-6. PubMed ID: 2787540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.
    Weiss HJ; Turitto VT; Baumgartner HR
    J Lab Clin Med; 1978 Nov; 92(5):750-64. PubMed ID: 309498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease.
    Weiss HJ; Tschopp TB; Baumgartner HR
    N Engl J Med; 1975 Sep; 293(13):619-23. PubMed ID: 1080251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of plasmin-induced aggregation of human platelets: implication of secreted von Willebrand factor.
    Rabhi-Sabile S; de Romeuf C; Pidard D
    Thromb Haemost; 1998 Jun; 79(6):1191-8. PubMed ID: 9657447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adhesion and aggregation in the subendothelium: hereditary platelet function disorder].
    Tschopp TB; Weiss HJ; Baumgartner HR
    Schweiz Med Wochenschr; 1975 Nov; 105(47):1587-9. PubMed ID: 1082165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease.
    Bütün II; Ekmekçi H; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):308-12. PubMed ID: 17636193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
    Yoshioka A; Takahashi Y
    Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
    [No Abstract]   [Full Text] [Related]  

  • 20. Von Willebrand's disease.
    Hoyer LW
    Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.